132 related articles for article (PubMed ID: 26199214)
1. Virtual Screening for Potential Inhibitors of High-Risk Human Papillomavirus 16 E6 Protein.
Kumar S; Jena L; Mohod K; Daf S; Varma AK
Interdiscip Sci; 2015 Jun; 7(2):136-42. PubMed ID: 26199214
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening for potential inhibitors of high-risk human papillomavirus 16 E6 protein.
Kumar S; Jena L; Mohod K; Daf S; Varma AK
Interdiscip Sci; 2015 Feb; ():. PubMed ID: 25663107
[TBL] [Abstract][Full Text] [Related]
3. A novel small-molecule inhibitor of the human papillomavirus E6-p53 interaction that reactivates p53 function and blocks cancer cells growth.
Celegato M; Messa L; Goracci L; Mercorelli B; Bertagnin C; Spyrakis F; Suarez I; Cousido-Siah A; Travé G; Banks L; Cruciani G; Palù G; Loregian A
Cancer Lett; 2020 Feb; 470():115-125. PubMed ID: 31693922
[TBL] [Abstract][Full Text] [Related]
4. An in silico appraisal of azoic and disulphide derivatives for anticancer activity against HPV E6 oncoprotein to medicate cervical cancer.
Choudhury AD; Choudhury MD; Chetia P; Chowdhury A; Talukdar AD
Comb Chem High Throughput Screen; 2014 Jan; 17(1):38-46. PubMed ID: 24164050
[TBL] [Abstract][Full Text] [Related]
5. Molecular modeling simulation studies reveal new potential inhibitors against HPV E6 protein.
Ricci-López J; Vidal-Limon A; Zunñiga M; Jimènez VA; Alderete JB; Brizuela CA; Aguila S
PLoS One; 2019; 14(3):e0213028. PubMed ID: 30875378
[TBL] [Abstract][Full Text] [Related]
6. Identification and characterization of small molecule human papillomavirus E6 inhibitors.
Malecka KA; Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Murphy ME; Marmorstein R
ACS Chem Biol; 2014 Jul; 9(7):1603-12. PubMed ID: 24854633
[TBL] [Abstract][Full Text] [Related]
7. Elucidating Molecular Interactions of Natural Inhibitors with HPV-16 E6 Oncoprotein through Docking Analysis.
Kumar S; Jena L; Galande S; Daf S; Mohod K; Varma AK
Genomics Inform; 2014 Jun; 12(2):64-70. PubMed ID: 25031569
[TBL] [Abstract][Full Text] [Related]
8. Structure based identification and characterization of flavonoids that disrupt human papillomavirus-16 E6 function.
Cherry JJ; Rietz A; Malinkevich A; Liu Y; Xie M; Bartolowits M; Davisson VJ; Baleja JD; Androphy EJ
PLoS One; 2013; 8(12):e84506. PubMed ID: 24376816
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential binding pocket on viral oncoprotein HPV16 E6: a promising anti-cancer target for small molecule drug discovery.
Kolluru S; Momoh R; Lin L; Mallareddy JR; Krstenansky JL
BMC Mol Cell Biol; 2019 Aug; 20(1):30. PubMed ID: 31387520
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Two Oncogenic Functional Sites of the HPV E6 Oncoprotein with a High-Affinity Bivalent Ligand.
Ramirez J; Poirson J; Foltz C; Chebaro Y; Schrapp M; Meyer A; Bonetta A; Forster A; Jacob Y; Masson M; Deryckère F; Travé G
Angew Chem Int Ed Engl; 2015 Jun; 54(27):7958-62. PubMed ID: 26014966
[TBL] [Abstract][Full Text] [Related]
11. Cellular binding partners of the human papillomavirus E6 protein.
Tungteakkhun SS; Duerksen-Hughes PJ
Arch Virol; 2008; 153(3):397-408. PubMed ID: 18172569
[TBL] [Abstract][Full Text] [Related]
12. Molecular Probing of the HPV-16 E6 Protein Alpha Helix Binding Groove with Small Molecule Inhibitors.
Rietz A; Petrov DP; Bartolowits M; DeSmet M; Davisson VJ; Androphy EJ
PLoS One; 2016; 11(2):e0149845. PubMed ID: 26915086
[TBL] [Abstract][Full Text] [Related]
13. The human papillomavirus (HPV) E6 oncoproteins promotes nuclear localization of active caspase 8.
Manzo-Merino J; Massimi P; Lizano M; Banks L
Virology; 2014 Feb; 450-451():146-52. PubMed ID: 24503077
[TBL] [Abstract][Full Text] [Related]
14. 3-(2-Chloropropyl amide)-4-methoxy-N-phenylbenzamide inhibits expression of HPV oncogenes in human cervical cancer cell.
Han F; Li Y; Lu Q; Ma L; Wang H; Jiang J; Li Z; Li Y
Virol J; 2017 Jul; 14(1):145. PubMed ID: 28754129
[TBL] [Abstract][Full Text] [Related]
15. Identification of inhibitors to papillomavirus type 16 E6 protein based on three-dimensional structures of interacting proteins.
Baleja JD; Cherry JJ; Liu Z; Gao H; Nicklaus MC; Voigt JH; Chen JJ; Androphy EJ
Antiviral Res; 2006 Oct; 72(1):49-59. PubMed ID: 16690141
[TBL] [Abstract][Full Text] [Related]
16. Eight-type human papillomavirus E6/E7 oncoprotein detection as a novel and promising triage strategy for managing HPV-positive women.
Rezhake R; Hu SY; Zhao S; Xu XQ; Zhao XL; Zhang L; Wang Y; Zhang X; Pan QJ; Qiao YL; Zhao FH
Int J Cancer; 2019 Jan; 144(1):34-42. PubMed ID: 29943809
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of the human papillomavirus-16 E6 oncoprotein by organic disulfides.
Beerheide W; Sim MM; Tan YJ; Bernard HU; Ting AE
Bioorg Med Chem; 2000 Nov; 8(11):2549-60. PubMed ID: 11092540
[TBL] [Abstract][Full Text] [Related]
18. Potential drugs against cervical cancer: zinc-ejecting inhibitors of the human papillomavirus type 16 E6 oncoprotein.
Beerheide W; Bernard HU; Tan YJ; Ganesan A; Rice WG; Ting AE
J Natl Cancer Inst; 1999 Jul; 91(14):1211-20. PubMed ID: 10413422
[TBL] [Abstract][Full Text] [Related]
19. REBACIN® as a noninvasive clinical intervention for high-risk human papillomavirus persistent infection.
Yang Y; Meng YL; Duan SM; Zhan SB; Guan RL; Yue TF; Kong LH; Zhou L; Deng LH; Huang C; Wang S; Wang GY; Wu DF; Zhang CF; Chen F
Int J Cancer; 2019 Nov; 145(10):2712-2719. PubMed ID: 30989655
[TBL] [Abstract][Full Text] [Related]
20. E7 oncoprotein of human papillomavirus: Structural dynamics and inhibitor screening study.
Aarthy M; Kumar D; Giri R; Singh SK
Gene; 2018 Jun; 658():159-177. PubMed ID: 29535023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
